Table 1.
Baseline Characteristics of the Sample
| Variable | Completed Post-treatment Follow-up (n = 45) |
Did Not Complete Post-treatment Follow-up (n = 27) |
Full Sample (N = 72) |
|||
|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | |
| Age | 46.53 | 9.08 | 43.63 | 11.09 | 45.44 | 9.91 |
| Years education | 14.51 | 1.96 | 13.74 | 2.01 | 14.22 | 2.00 |
| Severity of Sleep Disturbancea | 6.96 | 1.80 | 7.11 | 2.06 | 7.01 | 1.89 |
| n | % | n | % | n | % | |
| Racial-Ethnic Self-Identification | ||||||
| White, non-Hispanic | 18 | 40.00 | 12 | 44.44 | 30 | 41.67 |
| Black, non-Hispanic | 17 | 37.78 | 11 | 40.74 | 28 | 38.89 |
| Other Racial-Ethnic Self-Identification | 10 | 22.22 | 4 | 14.81 | 14 | 19.44 |
| Gender | ||||||
| Female | 34 | 75.55 | 26 | 96.29 | 60 | 83.33 |
| Male | 11 | 24.44 | 1 | 3.70 | 12 | 16.67 |
| Clinically Significant Sleep Disturbanceb | ||||||
| Yes | 45 | 100.00 | 27 | 100.00 | 72 | 100.00 |
| No | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |
a
Severity of Sleep Disturbance calculated by summing the first three items of the Quick Inventory of Depressive Symptomatology, Self-report Version.
b
Clinically Significant Sleep Disturbance identified using methodology by Soehner and colleagues (2014).